000			01858 a2200541 4500
005			20250513051509.0
264		0	_c19940913
008			199409s 0 0 eng d
022			_a0022-2623
024	7		_a10.1021/jm00042a008 _2doi
040			_aNLM _beng _cNLM
100	1		_aNorman, M H
245	0	0	_aCyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents. _h[electronic resource]
260			_bJournal of medicinal chemistry _cAug 1994
300			_a2552-63 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntipsychotic Agents _xchemical synthesis
650	0	4	_aApomorphine _xpharmacology
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aBinding, Competitive
650	0	4	_aCatalepsy _xchemically induced
650	0	4	_aCorpus Striatum _xmetabolism
650	0	4	_aCyclization
650	0	4	_aDopamine D2 Receptor Antagonists
650	0	4	_aFrontal Lobe _xmetabolism
650	0	4	_aHippocampus _xmetabolism
650	0	4	_aIndoles _xchemical synthesis
650	0	4	_aIsoindoles
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMolecular Structure
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aPhthalazines _xchemical synthesis
650	0	4	_aRadioligand Assay
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, Dopamine D2 _xmetabolism
650	0	4	_aReceptors, Serotonin _xmetabolism
650	0	4	_aSerotonin Antagonists
650	0	4	_aStructure-Activity Relationship
650	0	4	_aThiazoles _xchemical synthesis
700	1		_aRigdon, G C
700	1		_aNavas, F
700	1		_aCooper, B R
773	0		_tJournal of medicinal chemistry _gvol. 37 _gno. 16 _gp. 2552-63
856	4	0	_uhttps://doi.org/10.1021/jm00042a008 _zAvailable from publisher's website
999			_c7913869 _d7913869